Search Results
Jan 29, 2026, 10:07 ET Avobis Bio Announces Expanded Primary Analysis Results from the Randomized Multicenter STOMP2 Clinical Trial to be Presented at European Crohn's and Colitis Organisation (ECCO) Congress
deemed appropriate by treating investigator. Control arm subjects that received AVB-114 treatment in Part 2 were followed for an additional 52 weeks post-AVB-114 treatment. To ensure subject safety, study validity and scientific merit a blinded core lab analyzed MRIs and an independent data safety monitoring
More news about: Avobis Bio
Jan 29, 2026, 10:07 ET FOX SPORTS UNVEILS HISTORIC FIFA WORLD CUP 2026™ BROADCAST SCHEDULE
forward to the day ahead, will air between FOX and FS1 daily throughout the tournament, as will FIFA WORLD CUP™ TODAY, a bridge show delivering pre-and-post match insights and analysis. Coverage of all the FIFA World Cup 2026™ action produced by FOX Sports will feature an elite
More news about: Fox Corporation
Jan 29, 2026, 10:06 ET Sprout Pharmaceuticals' Addyi® (flibanserin) Named "Best Prescription for Low Libido" in the 2026 Oprah Daily Menopause O-wards
2025, the U.S. Food and Drug Administration expanded Addyi's approval from premenopausal women to include women with HSDD under 65 regardless of peri or post-menopausal status. This approval closed a long-standing gap in care and recognized Addyi's well-established safety and efficacy profile backed by more
More news about: Sprout Pharmaceuticals
Jan 29, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aquestive Therapeutics, Inc. - AQST
review of the Company's NDA for Anaphylm, the FDA notified us that it had identified deficiencies in the NDA that preclude discussion of labeling and post-marketing commitments at this time," stating that "the notification did not specify the deficiencies[.]" On this news, Aquestive's stock price
More news about: Pomerantz LLP
Jan 29, 2026, 10:00 ET Franchise Direct Australia Releases "How to Market Your Franchise Locally and Online"
customers to see important information before visiting the website, and targeted social media marketing enables the franchise to run promotions and post about specific products or services. Local SEO and paid ads are beneficial to franchises because they focus on local keywords, landing pages, and geo-targeting.
More news about: Franchise Direct AU
Jan 29, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Atara Biotherapeutics, Inc. - ATRA
Biologics License Application (BLA) as monotherapy treatment for adult and pediatric patients two years of age and older with Epstein-Barr virus positive post-transplant lymphoproliferative disease (EBV+ PTLD), who have received at least one prior therapy including an anti-CD20 containing regimen." Atara
More news about: Pomerantz LLP
Jan 29, 2026, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Beyond Meat, Inc. and Certain Officers - BYND
news, Beyond Meat's stock price fell $0.265 per share, or 16.01%, to close at $1.39 per share on November 3, 2025. On November 10, 2025, during post-market hours, Beyond Meat issued a press release announcing its financial results for Q3 2025. Among other results, Beyond Meat reported that its loss
More news about: Pomerantz LLP
Jan 29, 2026, 09:45 ET Northwest expanding partnership with Risepoint, support of three online graduate programs
Central office and special education director district level post-master's certificate
More news about: Risepoint
Jan 29, 2026, 09:30 ET Emplifi Customers Generate 4.5% Boost in Engagement on Instagram and 5.3% Lift in Reach
falling from 16.9% in Q1 2024 to 9.7% by Q4 2025, Emplifi customers saw a 4.5% increase in median post reach engagement rate, alongside a 15% increase in median post volume and a 5.3% lift in median post reach, demonstrating how brands are expanding both the quality and scale of their social presence
More news about: Emplifi Inc
Jan 29, 2026, 09:06 ET CLASS ACTION REMINDER: Berger Montague Advises Fermi Inc. (NASDAQ: FRMI) Investors to Inquire About a Securities Fraud Lawsuit by March 6, 2026
complex civil litigation, class actions, and mass torts in federal and state courts throughout the United States. With more than $2.4 billion in 2025 post-trial judgments alone, the Firm is a leader in the fields of complex litigation, antitrust, consumer protection, defective products, environmental law,
More news about: Berger Montague
Jan 29, 2026, 09:05 ET Axia Women's Health and Rutgers School of Nursing Partner to Expand Nurse-Midwifery Training
than 1,800 students on campuses in Newark, New Brunswick, and Blackwood, as well as online, Rutgers School of Nursing offers bachelor's master's, post-master's certificates, and doctoral programs preparing nurses to transform care across populations. The school also offers a wide range of professional development
More news about: Axia Women's Health
Jan 29, 2026, 09:00 ET NEXTBIOMEDICAL Secures Health Canada Approval for Nexsphere-F™ in Musculoskeletal Pain Embolization
reducing pain. Unlike permanent microspheres, Nexsphere-F™ is designed to naturally dissolve after embolization, significantly lowering the risk of post-procedural complications and supporting the growing clinical demand for osteoarthritis pain embolization.In addition to Canadian approval, Nexsphere-F™ is
More news about: NEXTBIOMEDICAL CO., LTD.
Jan 29, 2026, 09:00 ET Astronomer Announces the 2026 Astronomer Data Excellence Award Winners
blog post
More news about: Astronomer
Jan 29, 2026, 09:00 ET Decisions Named a Challenger in Inaugural Gartner® Magic Quadrant™ and Critical Capabilities for Decision Intelligence Platforms Report
read the company's in-depth blog post.Gartner DisclaimerGartner does not endorse any vendor, product, or service depicted in its research publications and does not
More news about: Decisions
Jan 29, 2026, 09:00 ET GIBO Upgrades GIBO Create for Scalable AIGC Short Film Production, Expanding Capabilities Across Partner Ecosystem
unprecedented speed and scale. The enhanced system integrates automated script structuring, scene composition, dialogue adaptation, visual generation, and post-production optimization into a unified workflow tailored specifically for short drama and episodic formats.Powering the Next Phase of Scalable
More news about: GIBO Holdings Ltd.
Jan 29, 2026, 09:00 ET Talos Extends Series B to $150M in Strategic Fundraise
The fundraising round brings the company's total amount raised in its Series B to $150 million. The post-money valuation will reach approximately $1.5 billion."We're proud to have some of the world's most respected institutions, most of them existing
More news about: Talos Trading
Jan 29, 2026, 09:00 ET Talos Extends Series B to $150M in Strategic Fundraise
The fundraising round brings the company's total amount raised in its Series B to $150 million. The post-money valuation will reach approximately $1.5 billion."We're proud to have some of the world's most respected institutions, most of them existing
More news about: Talos Trading
Jan 29, 2026, 09:00 ET Kansas City Doctors Respond to Local Primary Care Gaps
a hospitalist program with the St. Luke's-Shawnee Health System. He has spent his career caring for adults in the hospital, in primary care, and in post-acute and geriatric settings. As a third-generation physician, he describes medicine as something he grew up around and has remained committed to evidence-based
More news about: MDVIP
Jan 29, 2026, 08:43 ET INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Aquestive Therapeutics
of severe allergic reactions, including anaphylaxis. The FDA advised that the unidentified deficiencies currently prevent discussions of labeling and post-marketing requirements, raising concerns about the application's approvability ahead of the January 31, 2026, PDUFA action date.To learn more
More news about: Faruqi & Faruqi, LLP
Jan 29, 2026, 08:41 ET Aesthetic Launches FindGPT: The AI Fashion Discovery Platform Turning Inspiration into Instant Shopping
FindGPT, an AI-powered discovery app that makes any outfit or post instantly shoppable. Whether it's an Instagram outfit, creator GRWM, or celebrity street style, FindGPT turns moments of inspiration into personalized
More news about: Aesthetic
Jan 29, 2026, 08:31 ET SHAREHOLDER INVESTIGATION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Wealthfront
www.faruqilaw.com.Shares of Wealthfront Corporation declined sharply following the company's first post-IPO earnings release, pressured by disappointing asset flow figures and emerging investor concerns about strategic exposures underpinning its mortgage
More news about: Faruqi & Faruqi, LLP
Jan 29, 2026, 08:01 ET TaxAct® Expands Flexible Filing Options for the 2026 Tax Season
proceeds are typically available within 24 hours of IRS acceptance of tax return; it may take additional time for your financial institution to post the funds to your account. Available through February 28, 2026 with any federal fee-based consumer online 2025 return when you choose to receive a refund
More news about: TaxAct
Jan 29, 2026, 08:00 ET Mast Reforestation Sells and Delivers Market-First Biomass Burial Credits to Royal Bank of Canada, CNaught, and others
Biomass Carbon Removal and Storage (BiCRS) approach is the first to use its proceeds to fund critically needed post-wildfire reforestation.Proceeds from MT1 credit sales are directly funding post-wildfire reforestation surrounding the biomass burial site in Bighorn County in southern Montana. This area
More news about: Mast Reforestation
Jan 29, 2026, 08:00 ET Spectrum Dynamics Medical Receives FDA 510(k) Clearance for Veritas.AI™, Its AI-Powered Noise Reduction Platform for VERITON-CT
conventional denoising techniques, Veritas.AI performs seamlessly across a wide range of imaging conditions, from routine diagnostic scans to delayed post-therapy imaging.The Veritas.AI Noise Reduction suite includes dedicated applications optimized for specific clinical needs:Bone-IQ.AI,
More news about: Spectrum Dynamics Medical, Inc.
Jan 29, 2026, 08:00 ET Spectrum Dynamics Medical Receives FDA 510(k) Clearance for Veritas.AI™, Its AI-Powered Noise Reduction Platform for VERITON-CT
conventional denoising techniques, Veritas.AI performs seamlessly across a wide range of imaging conditions, from routine diagnostic scans to delayed post-therapy imaging.The Veritas.AI Noise Reduction suite includes dedicated applications optimized for specific clinical needs:Bone-IQ.AI,
More news about: Spectrum Dynamics Medical, Inc.